D

Devyser Diagnostics AB
STO:DVYSR

Watchlist Manager
Devyser Diagnostics AB
STO:DVYSR
Watchlist
Price: 119 SEK 3.48% Market Closed
Market Cap: 2B SEK
Have any thoughts about
Devyser Diagnostics AB?
Write Note

Devyser Diagnostics AB
Total Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Devyser Diagnostics AB
Total Assets Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Assets CAGR 3Y CAGR 5Y CAGR 10Y
D
Devyser Diagnostics AB
STO:DVYSR
Total Assets
kr510.1m
CAGR 3-Years
90%
CAGR 5-Years
60%
CAGR 10-Years
N/A
Biogaia AB
STO:BIOG B
Total Assets
kr2.3B
CAGR 3-Years
7%
CAGR 5-Years
29%
CAGR 10-Years
N/A
Bonesupport Holding AB
STO:BONEX
Total Assets
kr778.7m
CAGR 3-Years
31%
CAGR 5-Years
28%
CAGR 10-Years
N/A
Vitrolife AB
STO:VITR
Total Assets
kr16.9B
CAGR 3-Years
40%
CAGR 5-Years
52%
CAGR 10-Years
41%
Swedish Orphan Biovitrum AB (publ)
STO:SOBI
Total Assets
kr72.2B
CAGR 3-Years
16%
CAGR 5-Years
17%
CAGR 10-Years
27%
BioArctic AB
STO:BIOA B
Total Assets
kr1.2B
CAGR 3-Years
4%
CAGR 5-Years
-3%
CAGR 10-Years
N/A
No Stocks Found

Devyser Diagnostics AB
Glance View

Market Cap
2B SEK
Industry
Biotechnology

Devyser Diagnostics AB engages in the development, manufacture and sale of kits for genetic testing in routine diagnostics. The company is headquartered in Hagersten, Stockholm. The company went IPO on 2021-12-10. The products are used for complex deoxyribonucleic acid (DNA) testing in the areas of hereditary diseases, oncology, and post-transplantation monitoring in order to diagnose genetic diseases and target cancer treatment. The firm has since its inception developed and launched almost 30 products for routine diagnostic use, including Devyser Thrombophilia assay as well as Devyser Resolution XY for analysis of chromosomes X and Y. Devyser Diagnostics’ products are sold directly to the end customer or through hired distributors. The firm provides its products in more than 45 countries.

DVYSR Intrinsic Value
118.6 SEK
Fairly Valued
Intrinsic Value
Price
D

See Also

What is Devyser Diagnostics AB's Total Assets?
Total Assets
510.1m SEK

Based on the financial report for Dec 31, 2023, Devyser Diagnostics AB's Total Assets amounts to 510.1m SEK.

What is Devyser Diagnostics AB's Total Assets growth rate?
Total Assets CAGR 5Y
60%

Over the last year, the Total Assets growth was 2%. The average annual Total Assets growth rates for Devyser Diagnostics AB have been 90% over the past three years , 60% over the past five years .

Back to Top